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High fructose intake induces an insulin resistance state associated with metabolic syndrome (MS). The eﬀect of vascular
inﬂammation in this model is not completely addressed. The aim of this study was to evaluate vascular remodeling, inﬂammatory
and oxidative stress markers, and atheroma development in high-fructose diet-induced insulin resistance of ApoE-deﬁcient
mice (ApoE-KO). Mice were fed with either a normal chow or a 10% w/v fructose (HF) in drinking water over a period
of 8 weeks. Thereafter, plasma metabolic parameters, vascular remodeling, atheroma lesion size, inﬂammatory markers, and
NAD(P)H oxidase activity in the arteries were determined. HF diet induced a marked increase in plasma glucose, insulin,
and triglycerides in ApoE-KO mice, provoked vascular remodeling, enhanced expression of vascular cell-adhesion molecule-1
(VCAM-1) and matrix metalloprotease 9 (MMP-9) and enlarged atherosclerotic lesion in aortic and carotid arteries. NAD(P)H
oxidase activity was enhanced by fructose intake, and this eﬀect was attenuated by tempol, a superoxide dismutase mimetic, and
losartan, an Angiotensin II receptor antagonist. Our study results show that high-fructose-induced insulin resistance promotes a
proinﬂammatory and prooxidant state which accelerates atherosclerotic plaque formation in ApoE-KO mice.
1.Introduction
Insulin-resistant states, including the metabolic syndrome
(MS) and type 2 diabetes, have been strongly associated with
subclinical and clinical cardiovascular disease (CVD)[1].
Elevated blood glucose, hyperinsulinemia, dyslipidemia and,
oxidative stress are central components of MS which are
additionally associated with a “proatherogenic” phenotype
[2]. There are evidences indicating that structural and
functional changes in the vascular wall are involved in
cardiovascular alterations associated with MS [3], but the
mechanisms underlying are not completely addressed. Previ-
ous studies from our group showed that chronic fructose-fed
rats exhibited dyslipidemia, hyperglycemia, and endothelial
dysfunction, and it was suggested an important role for the
renin-angiotensin system (RAS) in the pathogenic mecha-
nisms involved in this model [4].
Arterial remodeling occurs under an atherosclerotic
plaque formation [5]. The propensity to accelerated lesion
formation in MS may involve altered vascular structure and
increased vascular inﬂammatory response. Delbosc et al.
[6] reported that mesenteric arterial media/lumen ratio was
higher in fructose-fed rats, and a potential association of
soluble adhesion molecules with atherosclerosis has been
postulated [7]. Vascular cell adhesion molecule-1 (VCAM-
1) is a cytokine-inducible member of the immunoglobulin
gene superfamily that is expressed by endothelial cells in
regions predisposed to atherosclerosis and at the borders2 Experimental Diabetes Research
of atherosclerotic plaques [7, 8]. VCAM-1 functions in
combination with other adhesion molecules during chronic
inﬂammation, activating NAD(P)H oxidase and endothelial
MMPs [9]. Oxidative stress and associated vascular damage
are mediators of vascular injury and inﬂammation in many
CVD including atherosclerosis [10]. NAD(P)H oxidase is
the major source of vascular reactive oxygen species (ROS)
and is expressed in endothelial cells, vascular smooth muscle
cells(VSMCs),ﬁbroblasts,andmonocyte/macrophages[11].
Extent data strongly support the hypothesis that oxidative
stress, induced via activation of NAD(P)H oxidase, plays
a causative role in atherosclerosis [12, 13]. ROS are able
to regulate cellular growth (hyperplastic or hypertrophic),
endothelial dysfunction, cell migration, and inﬂammation
[14]. ROS also induce the expression of matrix-degrading
enzymes such as matrix metalloproteinases (MMPs) which
are involved in vascular remodeling and are postulated to
participate in the pathogenesis of atherosclerosis [15]. We
aimed to study the association of fructose intake-induced
insulin resistance with the development of atherosclerotic
plaque in ApoE-KO mice, an experimental model of cardio-
vascular complications related to MS, and the relationship
between metabolic parameters, vascular inﬂammation, and
oxidative stress.
2. Methods
2.1. Animals and Diets. All animals were cared in accordance
with the Guiding Principles in the Care and Use of Animals
of the US National Institutes of Health. All procedures
were approved by the Animal Research Committee of the
Universidad Nacional de Cuyo (protocol approval no. 10089
CICUAL/2009). Male C57/BL6J wild type and ApoE-KO
mice 8 weeks of age (20 to 22g; The Jackson Laboratories,
Bar Harbor, ME) were used for this study. The animals
were maintained in a 22◦C room with a 12hour light/dark
cycle and received drinking water ad libitum and were fed a
standard commercialchow diet (GEPSA,Argentina). During
8 weeks, animals from each genotype were randomly divided
into two groups: control mice (n = 10), with free access
to tap water; fructose-fed (HF) mice (n = 10) receiving
10% (w/v) fructose (Parafarm, Argentina) in their drinking
water. Additional group of age-matched ApoE-KO mice
were given a control diet or HF during 4 weeks and then
were randomized to no treatment, Tempol (Sigma Aldrich,
St. Louis, MO, USA; 1mg/kg of body weight per day), or
losartan(Roemmers,Argentina,10mg/kgofbodyweightper
day), during 4 more weeks.
2.2. Biochemical Determinations. After overnight fasting
blood samples for glucose, insulin, triglycerides, and choles-
terol determinations were taken from mice, collected from
cardiac puncture under anesthesia at the end of the experi-
mental period. The plasma glucose, cholesterol, and triglyc-
eride concentrations were determined using commercial kits
by enzymatic colorimetric methods (GT Lab, BuenosAires,
Argentina). Insulin was measured by ELISA (Crystal Chem,
USA).
2.3. Histomorphometric Studies. Mice were euthanized by
cervical dislocation and were perfused in situ with chilled
phosphate-buﬀered saline. The proximal aorta and the
mesenteric artery tree were ﬁxed with 2% paraformaldehyde,
paraﬃn embedded, and mounted in a Micron microtome.
Consecutive sections (5µm thickness) were taken from 2 to
3 regions of the aortic arch separated by ∼60µma n df r o m
the mesenteric vascular tree. Three cross-sections from each
regionwerestainedwithhematoxylin/eosinorwithMasson’s
trichrome solution and examined the diameters of the wall
and the lumen, displayed in 20X optical microscope and
digitized images with the software Image Pro. The linear
relationship of superﬁcial lumen/media was calculated for
each vessel with the Scion Image software.
2.4.QuantiﬁcationofAtheroscleroticPlaques. Plaqueareawas
quantiﬁed by Oil-red-O staining of lipid deposits. Aortas
and whole right carotid arteries were incubated for 45min
with Oil red O (0.5% in 60% isopropyl alcohol). Excess stain
was removed with 60% isopropyl alcohol. Quantiﬁcation of
atherosclerosis was performed in the aortic arch region up to
thedescendingabdominalaortaandonthebifurcationofthe
right common carotid arteries by computer-assisted image
analysis as previously described in detail [16]. Subsequently
images of en face preparations of the whole mounted aorta
and the carotid arteries were taken and the percentage of
plaques in relation to the entire aortic surface was calculated
as plaque score in percent of total area using ImageJ 1.37 v
software (NIH).
In another group of animals the whole aorta and right
carotid arteries were dissected from mice, perfusion ﬁxed
in situ with 2% paraformaldehyde, paraﬃne m b e d d e d ,a n d
mounted in a microtome. Atherosclerotic lesion size in
cross-sections of the aortic sinus was quantiﬁed as the area
occupied by hematoxylin/eosin staining.
2.5. Determination of Vascular Markers of Inﬂammation.
Paraformaldehyde-ﬁxed sections of aorta or mesenteric
arteries were incubated with murine monoclonal antibody
against VCAM-1(1:500; BD) or rabbit polyclonal antibody
against MMP-9 (1:200; Santa Cruz), overnight at 4◦C, fol-
lowed by 1h incubation with FITC or Alexa red conjugated
secondary antibody, respectively. Sections were mounted
and visualized using ﬂuorescence microscopy. Total area
of antigen-speciﬁc ﬂuorescence staining per section was
quantiﬁed using WCIF ImageJ imaging software. Positively
stained areas were selected and measured using program-
speciﬁc tools. Two replicate measurements were averaged
f o re a c ht i s s u et y p ep e rm o u s e( n = 4–6) to obtain
data for statistical analysis. MMP-9 expression was also
determined by Western Blot analysis. Aortic tissues were
homogenized in 100µLl y s i sb u ﬀer supplemented with
protease inhibitors (Complete Mini; 1 tablet/1.5mL; Roche
Diagnostics, Mannheim, Germany). Samples were run on
12.5% Tris-HCl gels with Tris/glycine/SDS buﬀer and the
proteins detected; after transfer to PDVF membranes, using
rabbit-anti MMP-9 antibody (1:500; Santa Cruz Biotech-
nology, Santa Cruz, CA) and HRP-conjugated secondaryExperimental Diabetes Research 3
Table 1: Average plasma glucose, insulin, and lipid levels in WT and ApoE-KO mice fed with control diet or high fructose diet.
Glucose
(mg/dL) Insulin(ng/mL) Cholesterol
(mg/dL)
Triglycerides
(mg/dL)
WT-control diet 161.2 ± 0.6n d7 1 .41 ± 1.59 1 ±1.2
WT-fructose fed 142.7 ± 5.4 nd 130.35 ±6.3 83.8 ±0.7
ApoE-control diet 143.4 ± 25.90 .85 ±0.03 391.6 ±6.0 114.10 ±3.5
ApoE-fructose fed 216.2 ± 22.2∗ 1.27 ±0.19∗ 382.0 ±34.5 190.2 ±18.2∗
Values are the mean ± SD (n = 12)P<0.05 versus WT control diet, ∗P<0.001 versus ApoE control diet.
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Figure 1: Morphometric analysis of the middle layer of aorta (a) and mesenteric arteries (b) from WT and ApoE-KO mice fed regular chow
(Control diet) or high fructose diet (HF). ApoE-KO mice display a decreased lumen/media ratio in vessels walls from fructose-fed ApoE-KO
mice. Results are expressed as means (n = 8) ± S.E.M ∗∗P<0.001 versus ApoE control in aortic rings; ∗P<0.05 versus WT, §P<0.05
versus ApoE control in mesenteric arteries rings.4 Experimental Diabetes Research
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Figure 2: High fructose intake enhances atheroma development. (a) Representative of whole aorta artery and (b) representative of right
carotid artery staining with Oil-red O. Extent of atherosclerosis quantiﬁed as percent of plaque area in ApoE-KO mice fed control diet and
HF diet. (c) Cross-sections from the aortic sinus were stained with hematoxylin and eosin to quantify the lesion area. Results are expressed
as means (n = 8) ± S.E.M ∗P<0.05; ∗∗P<0.01 versus control diet.
antibody (1:10.000 Jackson laboratory, US) for 1h, proteins
were visualized by performing luminal-enhanced chemi-
luminescence. Loading of equal amounts of proteins was
conﬁrmed by reproving the membrane with an antibody
against tubulin antibody (1:100; Santa Cruz Biotechnology,
Santa Cruz, CA) and secondary HRP-conjugated antibody
(1:10.000 Jackson laboratory, US).
2.6. Detection of Tissue NAD(P)H Oxidase Activity. The
NAD(P)H-driven superoxide production, an estimate of
NAD(P)H oxidase activity, was measured in freshly dis-
sected aorta using lucigenin-enhanced chemiluminescence.
Longitudinally cut aortas were transferred to 96-well
optiplates (Packard, USA) containing 50mM phosphate
buﬀer, 150mM sucrose, 100µM NAD(P)H, and 5µMl u c i -
genin (N,N -dimethyl-9-9 -biacridianium, Sigma Aldrich,
St. Louis, MO, USA). Luminescence generated by the reac-
tion of tissue-derived superoxide and lucigenin was counted
at 20◦C with a microplate scintillation counter (Fluoroskan
Ascent, Thermo) running in kinetic mode with a 1min
interval for each sample. Luminescence measurements were
obtained every 15s for 25 minutes. Basal chemiluminescence
was measured in the tissue placed in the 96-well optiplate
(dark-adapted) with phosphate-sucrose buﬀer and 5µM
lucigenin before 100 µM NAD(P)H addition and subtracted
fromNAD(P)H-stimulatedluminescence.Driedtissueswere
weighed for calculation of normalized superoxide produc-
tio ne xp r essedasc ountspe rmin u t eandpe rmilligramo fdry
tissue.
2.7. Statistical Analysis. Results are reported as mean ±
S.E.M. Signiﬁcance was determined by nonparametric anal-
ysis using Mann-Whitney U test to detect a statistical
diﬀerence between group of interest and its control. Analyses
involving more than two groups were done by ANOVA
and Bonferroni’s post hoc test using Prism-4 software.
Diﬀerences were considered signiﬁcant at P<0.05.
3. Results
3.1. Eﬀects of High Fructose Diet on Biochemical Parameters.
Fructose intake slightly increased cholesterol levels in WTExperimental Diabetes Research 5
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Figure 3: Immunoﬂuorescence detection of VCAM-1 expression (green) in aorta and mesenteric arteries of ApoE KO mice fed control diet
or fructose-rich diet (HF). Quantiﬁcation of the ﬂuorescent signal was performed by ImageJ software. Results are expressed as means ±
S.E.M ∗P<0.05; ∗∗P<0.01 versus control diet.
mice compared to WT in a control diet, without changing
any of the others variables measured. In ApoE-KO mice 8
weeks of 10% fructose feeding in drinking water signiﬁcantly
increased the concentration of plasma glucose, insulin, and
triglycerides, compared to ApoE-KO mice in control diet,
with no changes in cholesterol levels (Table 1).
3.2. Eﬀects of High Fructose Diet on Vascular Remodeling.
We determined the structural changes in the arterial wall by
histological analysis of aorta and the mesenteric arteries. In
ApoE-KO mice fed with fructose, thickness of the middle
layer of both aorta (Figure 1(a)) and mesenteric arteries
(Figure 1(b)) signiﬁcantly increased compared to ApoE-
KO mice in a control diet, producing a lower ratio of
lumen/media in the vessels of fructose-fed ApoE-KO mice.
3.3. High Fructose Diet Enhances Atherosclerosis. We deter-
mined the eﬀects of fructose feeding on the development
of atherosclerosis in arteries from ApoE-KO mice. We
quantiﬁed the area of atheroma plaque by computerized
morphometryusingtwoindependentapproaches:(1)enface
Oil red O-stained mouse aortas and right carotid arteries
and (2) quantiﬁcation of the lesion area in aortic sinus
cross-sections. Fructose-treated mice displayed a signiﬁcant
induction in the area of Oil Red O-stained atherosclerotic
plaques in both aorta and right carotid arteries (Figures 2(a)
and 2(b), resp.), as compared with untreated mice. HF diet
increasedthelesionareaintheaorticsinusinApoE-KO mice
(Figure 2(c)).
3.4. Eﬀect of Fructose on Vascular Inﬂammation. Vascular
adhesion molecule (VCAM-1) is a hallmark of vascular
inﬂammation. Immunoﬂuorescence detection revealed a
markedly increased VCAM-1 expression in aorta, especially
on the endothelium, and within the vascular wall in
mesenteric arteries from ApoE-KO mice fed with HF diet
(Figure 3).
We also evaluated the expression of metalloproteinase 9
(MMP-9), another vascular inﬂammatory marker involved
in remodeling. MMP-9 expression, examined by immuno-
histochemistry and western blot, clearly increased in
fructose-fed ApoE-KO aorta tissue (Figure 4).
3.5. Eﬀect of Fructose on NAD(P)H Oxidase Activity.
NAD(P)H oxidase contributes to basal vascular superoxide
production. HF diet increased signiﬁcantly the NAD(P)H6 Experimental Diabetes Research
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Figure 4: Expression of MMP-9 in aorta from ApoE KO and WT mice fed control diet or fructose-rich diet (HF) determined by Western
Blot and immunoﬂorescence detection. Quantiﬁcation of the ﬂuorescent signal was performed by ImageJ software. Results are expressed as
means ± S.E.M ∗P<0.05 versus control diet. (MMP-9: red; Actin: green).
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Figure 5: NAD(P)H oxidase activity (relative light units: RLU/mg
dry tissue) in aorta of mice fed with control diet (n = 8) and mice
fed with HF diet (n = 8 )a l o n eo rw i t hT e m p o l( n = 8) or losartan
(n = 8). Results are expressed as means ± S.E.M. P< 0.001 versus
control.
oxidase activity, suggesting the involvement of oxidative
stress in this model. Four-week treatment with Tempol,
a membrane permeable superoxide dismutase mimetic, or
withlosartan,anAngiotensin-IIreceptor1(AT1)antagonist,
signiﬁcantly reduced vascular NAD(P)H oxidase activity in
aortas from ApoE KO mice in a HF diet (Figure 5).
4. Discussion
Most of the studies that utilize fructose intake to develop
an experimental model of MS use rat, an animal model
that is resistant to develop atheroma plaques and is not
suitable for studying inﬂammatory pathways implicated in
the development of atherosclerosis [17]. In this study we
induce a MS, characterized by hyperglycemia, hypertriglyc-
eridemia, and hyperinsulinemia in ApoE-deﬁcient mice, an
atherogenic-prone animal model, to investigate the eﬀect of
insulin resistance induced by fructose feeding on vascular
remodeling, vascular inﬂammation, oxidative stress, and
atheroma development. We ﬁrst noticed that high-fructose
diet promoted vascular remodeling, which is involved in the
pathogenesis of atherosclerosis. Due to the hemodynamic,
histological, and biological particularities in large and small
vessels, it is of great interest to investigate structural changes
in our model. Turnover of extracellular matrix components
andcellmigrationcausesstructuralchangesinthevesselwall
with either outward (adventitial/media) or inward (lumenal)
protrusion. It is postulated that outgrowth remodeling
occurred also in mesenteric artery [18], so we measured
the medial thickness of both large and small arteries. We
demonstrated that in fructose-fed ApoE-KO mice, the media
cross-section area from aortas and mesenteric arteries were
signiﬁcantly increased while lumen diameter was normal.
This remodeling format is similar to that found in fructose-
fed rats by Puyo et al. [19].Experimental Diabetes Research 7
One important feature we found was that fructose-
rich diet promotes a proatherogenic state in ApoE-KO
mice, independently of hypercholesterolemia, leading to
accelerate aortic and carotid atheroma development. It has
been demonstrated the involvement of inﬂammation in
vascular remodeling and atherogenesis, with the expression
of VCAM-1 in the vascular wall [17, 20]. Here we observed
that intimal VCAM-1 expression in small and large caliber
arteries was signiﬁcantly increased in fructose-treated ApoE
KO mice compared with control chow mice.
Diﬀerent components of the MS have been identiﬁed
as possible stimulus for the synthesis and activity of
MMPs.DiverseMMPshavebeenidentiﬁedinatherosclerotic
plaques and in regions of foam cell accumulation and have
been directly associated with plaque remodeling [21]a sw e l l
as plaque vulnerability [22]. In our study we found that high
fructose diet enhanced expression of MMP-9, a gelatinase
enzyme, in atheroma-free area of the vessels during early
stages of atherosclerosis development.
Oxidative stress and inﬂammation processes are key
components of atherosclerosis, from fatty streak forma-
tion to plaque rupture and thrombosis [23, 24]. Diets
rich in fructose can alter cellular metabolism via several
pathways, thereby accelerating oxidative stress. Fructose
feeding results in the activation of the renin-angiotensin
system [25], and it is well established that angiotensin II is
associated with oxidative stress [26]. This oxidative stress is
characterized by overproduction of ROS and is dependent
on the activation of NAD(P)H oxidase. We found that
fructose-rich diet increased NAD(P)H oxidase activity in
ApoE-KO mice, and this enhancement is diminished by
Tempol, a superoxide dismutase mimetic, and by losartan,
an Angiotensin-II receptor 1 (AT1) inhibitor, corroborating
the role of superoxide generation in fructose-induced insulin
resistance and suggesting the involvement of the renin-
angiotensin system in the enhanced oxidative stress in our
model.
Our results show that insulin resistance associated with
MS promotes the initial stages of a proinﬂammatory and
a prooxidant state. These changes potentially contribute
to enhancing vascular remodeling and atheroma plaque
development and placing the insulin resistance as a potent
atherogenic risk factor.
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